Department of Otolaryngology & Head and Neck Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, China.
Department of Otolaryngology & Head and Neck Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
Cell Mol Biol (Noisy-le-grand). 2024 Jul 28;70(7):134-142. doi: 10.14715/cmb/2024.70.7.19.
Autosomal recessive non-syndromic hearing loss (ARNSHL) can cause severe or very severe pre-speech hearing loss. Transmembrane channel-like 1 (TMC1) gene is the sixth deafness gene discovered, but the precise extent of its protein structure and function is unknown. First, history collection, audiology examination and imaging examination were performed on the proband and his family members. Peripheral blood of proband and family members was collected, genomic DNA was extracted, exon high-throughput sequencing technology was used to detect the deafness gene mutation of the proband, and Sanger sequencing was performed to verify the TMC1 gene of the proband's parents. The proband was born with hearing impairment, normal tympanic function, inability to induce acoustic reflex in both ears (acoustic reflex threshold is 100 dBHL), and severe sensorineural deafness. One of his sisters has severe sensorineural hearing loss, and neither his parents nor his other sister is hearing impaired. High-throughput sequencing of the proband identified mutations at c.741+3_741+6delAAGT (splicing) and c.884C>T (p.A295V) of the TMC1 gene, two of which were heterozygous mutations. Sanger sequencing confirmed that the c.884C > T mutation was inherited from the mother, while the c.741+3_741+6delAAGT mutation was derived from the father. Prediction of amino acid function suggested that both mutations were pathogenic mutations. In conclusion, we found a new pathogenic complex heterozygous mutation of the TMC1 gene, which enriched the mutation spectrum of the TMC1 gene and provided a basis for genetic counseling and prenatal diagnosis of ARNSHL.
常染色体隐性非综合征型听力损失(ARNSHL)可导致严重或极重度语前听力损失。跨膜通道样 1(TMC1)基因是第六个被发现的耳聋基因,但对其确切的蛋白质结构和功能尚不清楚。首先,对先证者及其家系成员进行病史采集、听力学检查和影像学检查。采集先证者及其家系成员外周血,提取基因组 DNA,采用外显子高通量测序技术检测先证者耳聋基因突变,对先证者 TMC1 基因进行 Sanger 测序验证。先证者出生时即有听力损失,鼓膜正常,双耳无法引出声反射(声反射阈值 100dBHL),为重度感音神经性聋。其 1 位姐姐亦有重度感音神经性听力损失,先证者父母及另 1 位姐姐听力正常。先证者高通量测序发现 TMC1 基因 c.741+3_741+6delAAGT(剪接)和 c.884C>T(p.A295V)两处杂合突变,均为致病性突变。Sanger 测序证实 c.884C>T 突变来源于母亲,c.741+3_741+6delAAGT 突变来源于父亲。氨基酸功能预测提示两处突变均为致病性突变。综上,发现了 TMC1 基因的 1 种新的复合杂合致病性突变,丰富了 TMC1 基因的突变谱,为 ARNSHL 的遗传咨询和产前诊断提供了依据。